Evidence map›Paper›PMID 38524800›Full record

ArticleJournal of applied statistics2024

Selection of the optimal personalized treatment from multiple treatments with right-censored multivariate outcome measures.

Chathura Siriwardhana, K B Kulasekera, Somnath Datta

Abstract read
In one paragraph

Article in Journal of applied statistics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Chathura SiriwardhanaDepartment of Quantitative Health Sciences, University of Hawaii John A. Burns School of Medicine, Honolulu, HI, USA.ORCID https://orcid.org/0000-0002-5424-003X
K B KulasekeraDepartment of Bioinformatics & Biostatistics, University of Louisville, Louisville, KY, USA.ORCID https://orcid.org/0000-0001-7938-7217
Somnath DattaDepartment of Biostatistics, University of Florida, Gainesville, FL, USA.ORCID https://orcid.org/0000-0003-4381-1842

Funding

The Role of gp120 on Cardiovascular Disease in People Living with HIVU54MD007601 · NIMHD · UNIVERSITY OF HAWAII AT MANOA · PI Jerris Robert Hedges · 2017 to 2026
$59.5M
NIMHD NIH HHS U54 MD007601
6 · The paper itself

Abstract

We propose a novel personalized concept for the optimal treatment selection for a situation where the response is a multivariate vector that could contain right-censored variables such as survival time. The proposed method can be applied with any number of treatments and outcome variables, under a broad set of models. Following a working semiparametric Single Index Model that relates covariates and responses, we first define a patient-specific composite score, constructed from individual covariates. We then estimate conditional means of each response, given the patient score, correspond to each treatment, using a nonparametric smooth estimator. Next, a rank aggregation technique is applied to estimate an ordering of treatments based on ranked lists of treatment performance measures given by conditional means. We handle the right-censored data by incorporating the inverse probability of censoring weighting to the corresponding estimators. An empirical study illustrates the performance of the proposed method in finite sample problems. To show the applicability of the proposed procedure for real data, we also present a data analysis using HIV clinical trial data, that contained a right-censored survival event as one of the endpoints.

Indexed as

05D4042A6146N3065C6092B15Design variablespersonalized treatmentsrank aggregationright-censoringsingle index models

Identifiers

PMID38524800
PMCPMC10956931

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.